Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: Meta-analysis [PDF]
Vojnosanitetski Pregled, 2018 Background/Aim. Reslizumab is humanized monoclonal antibody produced by recombinant DNA technology which binds to circulating interleukin-5 (IL-5) and down-regulates the IL-5 signaling pathway. Reslizumab is indicated for the add-on maintenance treatment
Milosavljević Miloš N. +5 more
doaj +1 more source
Plants, 2023 Plants of the genus Tylophora have commonly been used in traditional medicine in various communities, especially in the tropical and subtropical regions of climatic zones.
Ehab M. Mostafa +10 more
doaj +1 more source
Journal of Asthma and Allergy, 2022 Ireland the fourth highest prevalence of asthma globally, with over 470,000 people with an asthma diagnosis. 1 In general, asthma symptoms can be controlled with inhaled corticosteroids, with the addition of a long-acting β 2 -agonist as indicated ...
Emily O’Reilly +8 more
semanticscholar +1 more source
Diagnosis and management of eosinophilic asthma: a US perspective. [PDF]
, 2014 Eosinophilic asthma is now recognized as an important subphenotype of asthma based on the pattern of inflammatory cellular infiltrate in the airway. Eosinophilic asthma can be associated with increased asthma severity, atopy, late-onset disease, and ...
Doherty, Taylor A, Walford, Hannah H
core +1 more source
Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III [PDF]
The Korean Journal of Internal MedicineBackground/Aims Despite short-acting β2-agonist (SABA) overuse being associated with poor asthma outcomes, data on SABA use in South Korea is scarce.
Kwang-Ha Yoo +6 more
doaj +1 more source
Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma [PDF]
, 2013 Peer reviewedPublisher ...
Walsh, Garry Michael
core +2 more sources
Allergic bronchopulmonary aspergillosis: diagnostic and treatment challenges [PDF]
, 2016 Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens.
CINICOLA, BIANCA LAURA +3 more
core +1 more source
Use of Anti-Asthmatic Medications in Elderly Taiwanese Patients
Kaohsiung Journal of Medical Sciences, 2003 The aim of this study was to assess the use of anti-asthmatic medications in Taiwanese geriatric asthmatic patients. We used computerized prescription databases from the National Health Insurance Program, Taiwan, and classified drugs according to the ...
Chi-Yu Chen
doaj +1 more source
Airway responses and inflammation in subjects with asthma after four days of repeated high-single-dose allergen challenge [PDF]
, 2012 Background: Both standard and low-dose allergen provocations are an established tool in asthma research to improve our understanding of the pathophysiological mechanism of allergic asthma.
Rose, Markus A. +5 more
core +2 more sources
Antagonism of cytokine-induced eosinophil accumulation in asthma [PDF]
, 2012 Peer reviewedPublisher ...
Walsh, Garry M.
core +2 more sources